ADVFN Logo ADVFN
Donnée du Marché
Actualité
Outils
Donnée du Marché
Discover

Hot Features

Follow Feed

Rester connecter avec les traders et investisseurs dans notre communauté Follow Feed.

Flux des Options

Explorez des données complètes sur les options et utilisez les filtres avancés avec Options Flow.

Moniteur

Organisez et surveillez vos d'actions et actifs avec le Moniteur.
Se connecter Premium IconPremium Help Menu
CAC 40
7 583,41
-0,65%
Dow Jones
40 211,72
0,53%
DAX
18 493,44
-0,57%
Brent Oil
83,695
-0,76%
Bitcoin
63 070,79
-2,75%
Registration Strip Icon for monitor Surveillez plusieurs cotations en temps réel des principales bourses, telles que Euronext Paris, NASDAQ, NYSE, AMEX, Bovespa et plus encore.
S'inscrire
  1. Accueil
  2. Investir
  3. Actions
  4. Etats-Unis
  5. NYSE
  6. Teva Pharmaceutical Industries Ltd (TEVA)

  7. Teva Pharmaceutical Industries Ltd (TEVA) Actualités

TEVA

Teva Pharmaceutical Indu... (TEVA)

Teva Pharmaceutical Industries Ltd
De:
Trier par:
 Showing the most relevant articles for your search:NYSE:TEVA
DateHeureSourceTitreSymboleSociété
18/10/202214h00Business WireTeva Announces Results from 3-Year Study Assessing the Safety and Tolerability of AUSTEDO® (deutetrabenazine) Tablets for the Treatment of Chorea Associated with Huntington’s DiseaseNYSE:TEVATeva Pharmaceutical Industries Ltd
10/10/202212h39Dow Jones NewsTeva Might Have Broken Competition Rules, EU Watchdog Says -- UpdateNYSE:TEVATeva Pharmaceutical Industries Ltd
10/10/202210h34Dow Jones NewsEU Watchdog Says Teva Might Have Misused Patent System to Hinder CompetitionNYSE:TEVATeva Pharmaceutical Industries Ltd
07/10/202222h44TipRanksTeva tells Bloomberg it sees Adderall supply issues for next 2-3 monthsNYSE:TEVATeva Pharmaceutical Industries Ltd
07/10/202217h01Dow Jones NewsCorrection to Teva ArticleNYSE:TEVATeva Pharmaceutical Industries Ltd
07/10/202215h18Dow Jones NewsTeva Pharmaceutical Reaches Fourth U.S. Settlement Over Price-Fixing ClaimsNYSE:TEVATeva Pharmaceutical Industries Ltd
07/10/202214h30Business WireTeva Reaches Agreement With Arkansas to Settle the State’s Price Fixing ClaimsNYSE:TEVATeva Pharmaceutical Industries Ltd
06/10/202222h00Business WireTeva to Host Conference Call to Discuss Third Quarter 2022 Financial Results at 8 a.m. ET on November 3, 2022NYSE:TEVATeva Pharmaceutical Industries Ltd
06/10/202214h34Business WireTeva Announces Largest-Ever Trial to Collect Information from Patients and Physicians About TD, its Impact and Progression Over Time, and Evaluate Treatment-Related OutcomesNYSE:TEVATeva Pharmaceutical Industries Ltd
30/09/202215h00Dow Jones NewsTeva Pharmaceutical Reaches Third State Settlement Over Price-Fixing ClaimsNYSE:TEVATeva Pharmaceutical Industries Ltd
30/09/202214h00Business WireTeva Reaches Agreement With Georgia to Settle the State’s Price Fixing ClaimsNYSE:TEVATeva Pharmaceutical Industries Ltd
26/09/202214h00Business WireTeva Launches Honestly HD Website to Provide People Living With Huntington’s Disease (HD) Information, Inspiration and Resources on HD ChoreaNYSE:TEVATeva Pharmaceutical Industries Ltd
08/09/202221h58Business WireDes études démontrent l'efficacité d'AJOVY®▼ (frémanézumab) dans le traitement de la migraine chez des patients présentant une dépression comorbideNYSE:TEVATeva Pharmaceutical Industries Ltd
08/09/202220h29Business WireStudien zeigen Wirksamkeit von AJOVY®▼ (Fremanezumab) bei der Behandlung von Migräne bei Patientinnen und Patienten mit komorbider DepressionNYSE:TEVATeva Pharmaceutical Industries Ltd
08/09/202207h45Business WireStudies Show Effectiveness of AJOVY®▼ (fremanezumab) for Treatment of Migraine in Patients With Co-morbid DepressionNYSE:TEVATeva Pharmaceutical Industries Ltd
07/09/202214h00Business WireCONNECT1 Study Published in Journal of Allergy and Clinical Immunology: In Practice Evaluates the Potential of ProAir® Digihaler® (albuterol sulfate) Inhalation Powder and Digihaler System to Help Improve Asthma ManagementNYSE:TEVATeva Pharmaceutical Industries Ltd
29/08/202218h26Business WireLa Commission européenne accorde une autorisation de mise sur le marché à Ranivisio▼®* (ranibizumab), un biosimilaire du Lucentis®**, pour le traitement de la dégénérescence maculaire liée à l'âge (DMLA), cause la plus fréquente de cécité dNYSE:TEVATeva Pharmaceutical Industries Ltd
29/08/202217h56Business WireEuropäische Kommission erteilt Marktzulassung für Ranivisio▼®* (Ranibizumab), ein Biosimilar von Lucentis®** zur Behandlung von altersbedingter Makuladegeneration (AMD), der häufigsten Ursache für Erblindung in IndustrieländernNYSE:TEVATeva Pharmaceutical Industries Ltd
29/08/202214h00Business WireTeva to Present First Data Set from the CONNECT1 Clinical Trial on ProAir® Digihaler® (albuterol sulfate) Inhalation Powder at the European Respiratory Society (ERS) International Congress 2022NYSE:TEVATeva Pharmaceutical Industries Ltd
29/08/202208h00Business WireEuropean Commission grants marketing authorization for Ranivisio▼®* (ranibizumab), a biosimilar to Lucentis®**, for age-related macular degeneration (AMD) the most common cause of blindness in developed countriesNYSE:TEVATeva Pharmaceutical Industries Ltd
24/08/202213h51Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NYSE:TEVATeva Pharmaceutical Industries Ltd
03/08/202213h11Edgar (US Regulatory)Initial Statement of Beneficial Ownership (3)NYSE:TEVATeva Pharmaceutical Industries Ltd
02/08/202214h36TipRanksAnalysts’ Opinions Are Mixed on These Healthcare Stocks: Teva Pharmaceutical (TEVA), HUTCHMED (HCM) and Arcutis Biotherapeutics (ARQT)NYSE:TEVATeva Pharmaceutical Industries Ltd
29/07/202214h21TipRanksJ.P. Morgan Maintains Their Hold Rating on Teva Pharmaceutical (TEVA)NYSE:TEVATeva Pharmaceutical Industries Ltd
27/07/202222h07Edgar (US Regulatory)Quarterly Report (10-q)NYSE:TEVATeva Pharmaceutical Industries Ltd
27/07/202216h21TipRanksHere’s Why Teva Shares are Trending Higher TodayNYSE:TEVATeva Pharmaceutical Industries Ltd
27/07/202213h31TipRanksThese Stocks Are the Biggest Pre-Market Movers on WednesdayNYSE:TEVATeva Pharmaceutical Industries Ltd
26/07/202223h53Dow Jones NewsTeva Pharma ADRs Jump 17% On Pending Nationwide Agreement Over Opioid LitigationNYSE:TEVATeva Pharmaceutical Industries Ltd
26/07/202222h55Business WireTeva Reports Second Quarter 2022 Financial ResultsNYSE:TEVATeva Pharmaceutical Industries Ltd
25/07/202214h00GlobeNewswire Inc.Certara Appoints Rosemary Crane as New Independent Board MemberNYSE:TEVATeva Pharmaceutical Industries Ltd
 Showing the most relevant articles for your search:NYSE:TEVA

Dernières Valeurs Consultées

COIN
FETUSD
Fetch
USOTC
SGGFF
iPath Bloomberg Sugar Su... (PK)
LSE
AGLD
Allied Gold
NASDAQ
TETCU
Tech and Energy Transition
BIT
P22041
NLBNPIT22041 20991231 2....
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

France
Société
Entreprise
Popular
Obtenir l'application
App Store
Google Play

Assistance: support@advfn.fr

En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales

© 2024 ADVFN PLC - Tous droits réservés